Drug recall · May 31, 2017
Children's Cetirizine Hydrochloride Chewable Tablets recall
Why: Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Children's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol - 389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 47335-343-83.
- Lots / codes
Lot #: JKR5135A, Exp 11/17
- Quantity
- 13,200 bottles
- Company
- Sun Pharmaceutical Industries, Inc., Cranbury, NJ
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- April 18, 2017 · Voluntary: Firm initiated
- Classified
- May 23, 2017
- Reported
- May 31, 2017
- Ended
- May 18, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cetirizine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.